Sialidase in Brain and Fibroblasts in Three Patients with Different Types of Sialidosis

  • Bernhard Pallmann
  • Konrad Sandhoff
  • Bruno Berra
  • Tadashi Miyatake
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 125)


In recent years numerous diseases have become known which are characterized by an elevated urinary excretion of sialooligosaccharides and a deficiency of sialidase in cultured fibroblasts (for literature, see SPRANGER, GEHLER and CANTZ, 1977; STRECKER and MICHALSKI, 1978; MAROTEAUX, 1978).


Sialic Acid Lysosomal Enzyme Postmortem Brain Lysosomal Storage Disease Sialic Acid Content 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. BERRA B., CESTARO B., OMODEO-SALE F., VENERANDO B., BELTRAME D., and CANTONE A. (1978): Gangliosides and neuraminidases in foetal rat brain. Bull. Mol. Biol. Med. 3, 86–97.Google Scholar
  2. CANTZ M., GEHLER J. and SPRANGER J. (1977): Mucolipidosis I: Increased sialic acid content and deficiency of an a-N-acetylneuraminidase in cultured fibroblasts. Biochem. Biophys. Res. Commun. 74, 723–738.Google Scholar
  3. CHRISTOMANOU H., CAP C. and SANDHOFF K. (1977): Isoelectric focusing pattern of acid hydrolases in cultured fibroblasts, leucocytes and cell-free amniotic fluid. Neuropädiatrie 8, 238–252.PubMedCrossRefGoogle Scholar
  4. COPPA G., SANI S., PARIS D., GABRIELLI O. and MARIORANA A. (1979): Isoelectric focusing of serum lysosomal enzymes and characterization of urinary and tissutal glycosaminoglycans in I-cell disease (mucolipidosis II), in “Perspect. Inher. Metab. Dis. II”, BERRA B. et al.,Eds., Edi Ermes Publ. (Milano), in press.Google Scholar
  5. DURAND P., GATTI R., CAVALIERI S., BORRONE C., TONDEUR M., MICHALSKI J.C. and STRECKER G. (1977): Sialidosis (mucolipidosis I). Heiv. paediat. Acta 32, 391–400.Google Scholar
  6. GOLDSTEIN M.L., KOLODNY E.H., GASCON G.G. et al. (1974): Macular cherry-red spot, myoclonic epilepsy, and neurovisceral storage in a 17-year old girl. Trans. Am. Neurol. Assoc. 99, 110–112.Google Scholar
  7. HICKMANN S. and NEUFELD E.F. (1972): A hypothesis for I-cell disease: defective hydrolases that do not enter lysosomes. Biochem. Biophys. Res. Commun. 49, 992–999.CrossRefGoogle Scholar
  8. HOLMES E.W., MILLER A.L., FROST R.G. and O’BRIEN J.S. (1975): Characterization of ß-D-galactosidase isolated from I-cell disease liver. Am. J. Hum. Genet. 27, 719–727.Google Scholar
  9. HUMBEL R. and COLLART M. (1975): Oligosaccharides in urine of patients with glycoprotein storage disease. Clin. Chim. Acta 60, 143–145.PubMedCrossRefGoogle Scholar
  10. KAPLAN A., ACHORD D.T. and SLY W.S. (1977): Phosphohexosyl components of a lysosomal enzyme are recognized by pinocytosis receptors on human fibroblasts. Proc. Natl. Acad. Sci. 74, 2026–2030.Google Scholar
  11. KELLY T.E. and GRAETZ G. (1977): Isolated acid neuraminidase deficiency: A distinct lysosomal storage disease. Am. J. Med. Genet. 1, 31–46.PubMedCrossRefGoogle Scholar
  12. KRESS B.C. and MILLER A.L. (1978): Altered serum a-D-mannosidase activity in mucolipidosis II and mucolipidosis III. Biochem. Biophys. Res. Commun. 81, 756–763.PubMedCrossRefGoogle Scholar
  13. LEROY G.J., HO M.W., MACBRINN M.C., ZIELKE K., JAKOB J. and O’BRIEN J.S. (1972): I-cell disease: Biochemical studies. Pediat. Res. 6, 752–757.Google Scholar
  14. LOWRY O.H., ROSEBROUGH N.J., FARR A.L. and RANDALL R.J. (1951): Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265–275.Google Scholar
  15. MAIRE I., ZABOT M.T., MATHIEU M. and COTTE J. (1978): Mannosidosis: tissue culture studies in relation to prenatal diagnosis. J. Inher. Metab. Dis. 1, 19–23.Google Scholar
  16. MAROTEAUX P. and HUMBEL R. (1976): Les oligosaccharidoses. Un nouveau concept. Arch. Franç. Péd. 23, 641–647.Google Scholar
  17. MAROTEAUX P. (1978): Les sialidoses par déficit en a-2–6 neuraminidase: Un groupe hétérogène. Arch. Franç. Péd. 35, 815–818.Google Scholar
  18. MICHALSKI J.C. and STRECKER G. (1977): in “Les Oligosaccharidoses”, FARRIAUX J.P., Ed., Crouan-Roques (Lille), pp. 127–130.Google Scholar
  19. MIYATAKE T., YAMADA T., SUZUKI M., PALLMANN B., SANDHOFF K., ARIGA T. and ATSUMI T. (1979a): Sialidase deficiency in adult-type neuronal storage disease. FEBS Lett. 97, 257–259.PubMedCrossRefGoogle Scholar
  20. MIYATAKE T., ATSUMI T., OBAYASHI T., MIZUNO Y., ANDO S., ARIGA T., MATSUI-NAKAMURA K. and YAMADA T. (1979b): Adult type neuronal storage disease with neuraminidase deficiency. Ann. Neurol. in press.Google Scholar
  21. O’BRIEN J.S. (1978): The cherry-red spot myoclonus syndrome: A newly recognized inherited lysosomal storage disease due to acid neuraminidase deficiency. Clin. Genet. 14, 55–60.PubMedCrossRefGoogle Scholar
  22. RAPIN I., GOLDFISCHER S., KATZMANN R., ENGEL J. and O’BRIEN J.S. (1978): The cherry-red spot myoclonus syndrome. Ann. Neurol. 3, 234–242.Google Scholar
  23. SCHRAVEN J., CAP C., NOWOCZEK G. and SANDHOFF K. (1977): A radiometric assay for sialidase acting on ganglioside GD1a. Anal. Biochem. 78, 333–339.Google Scholar
  24. SCHWARZMANN G. (1978): A simple and novel method for tritium labeling of gangliosides and other sphingolipids. Biochim. Biophys. Acta 529, 106–114.PubMedCrossRefGoogle Scholar
  25. SPRANGER J., WIEDEMANN H.R., TOLKSDORF M., GRAUCOB E. and CAESAR R. (1968): Lipomucopolysaccharidosis: a new storage disease. Z. Kinderheilk. 103, 285–306.PubMedCrossRefGoogle Scholar
  26. SPRANGER J., GEHLER J. and CANTZ M. (1977): Mucolipidosis I - a sialidosis. Am. J. Med. Genet. 1, 21–29.Google Scholar
  27. SPRITZ R.A., COATES P.M. and LIEF F.S. (1979): I-cell disease: intracellular desialylation of lysosomal enzymes using an influenza virus vector. Biochim. Biophys. Acta 582, 164–171.Google Scholar
  28. STRECKER G., MICHALSKI J.C., MONTREUIL J. and FARRIAUX J.P. (1976): Deficit in neuraminidase associated with mucolipidosis II ( I-cell disease ). Biomedicine 25, 238–240.Google Scholar
  29. STRECKER G., PEERS M.C., MICHALSKI J.C., HONDI-ASSAH T., FOURNET B., SPIK G., MONTREUIL J., FARRIAUX J.P., MAROTEAUX P. and DURAND P. (1977): Structure of nine sialyloligosaccharides accumulated in urine of eleven patients with three different types of sialidosis, mucolipidosis II and two new types of mucolipidosis. Eur. J. Biochem. 75, 391–403.Google Scholar
  30. STRECKER G. and MICHALSKI J.C. (1978): Biochemical basis of six different types of sialidosis. FEBS Lett. 85, 20–24.PubMedCrossRefGoogle Scholar
  31. TETTAMANTI G., BONALI F., MARCHESINI S. and ZAMBOTTI V. (1973): A new procedure for the extraction, purification and fractionation of brain gangliosides. Biochim. Biophys. Acta 296, 160–170.Google Scholar
  32. THOMAS G.H., TAYLOR H.A., REYNOLDS L.W. and MILLER C.S. (1973): Mucolipidoses III (pseudo-Hurler polydystrophy): multiple lysosomal abnormalities in serum and cultured fibroblast cells. Pediat. Res. 7, 751–756.Google Scholar
  33. THOMAS G.H., TIPTON R.E., CH’IEN L.T., REYNOLDS L.W. and MILLER C.S. (1978): Sialidase (a-N-acetylneuraminidase) deficiency: the enzyme defect in an adult with macular cherry-red spots and myoclonus without dementia. Clin. Genet. 13, 369–379.Google Scholar
  34. TONDEUR M., VAMOS-HURWITZ E., MOCKEL-POHL S., DEREUME J.P., CREMER N. and LOEB H. (1971): Clinical, biochemical and ultrastructural studies in a case of chondrodystrophy presenting in I-cell phenotype in tissue culture. J. Pediatr. 79, 366–378.PubMedCrossRefGoogle Scholar
  35. ULLRICH K., MERSMANN G., WEBER E. and v. FIGURA K. (1978): Evidence for lysosomal enzyme recognition by human fibroblasts via a phosphorylated carbohydrate moiety. Biochem- J. 170, 643–650.Google Scholar
  36. VLADUTIU G.D. and RATTAZZI M.C. (1975): Abnormal lysosomal hydrolases excreted by cultured fibroblasts in I-cell disease (mucolipidosis II). Biochem. Biophys. Res. Commun. 67, 956–963.PubMedCrossRefGoogle Scholar
  37. VLADUTIU G.D. and RATTAZZI M.C. (1978): I-cell disease: desialylation of ß-hexosaminidase and its effect on uptake by fibroblasts. Biochim. Biophys. Acta 539, 31–36.PubMedCrossRefGoogle Scholar
  38. WARREN L. (1959): The thiobarbituric acid assay of sialic acids. J. Biol. Chem. 234, 1971–1975.PubMedGoogle Scholar
  39. WENGER D.A., TARBY T.J. and WHARTON C. (1978): Macular cherry-red spots and myoclonus with dementia: coexistent neuraminidase ß-galactosidase deficiencies. Biochem. Biophys. Res. Commun. 82, 589–595.Google Scholar
  40. WIESMANN U.N. and HERSCHKOWITZ N.N. (1974): Studies on the pathogenetic mechanism of I-cell disease in cultured fibroblasts. Pediat. Res. 8, 865–870.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1980

Authors and Affiliations

  • Bernhard Pallmann
    • 1
  • Konrad Sandhoff
    • 1
  • Bruno Berra
    • 2
  • Tadashi Miyatake
    • 3
  1. 1.Neurochemische AbteilungMax-Planck-Institut für PsychiatrieMünchen 40Germany
  2. 2.College of PharmacyUniversity of MilanItaly
  3. 3.Department of NeurologyJichi Medical SchoolYakushiji, TochigiJapan

Personalised recommendations